Paratek Pharmaceuticals Inc (NASDAQ:PRTK)

30.41
Delayed Data
As of Feb 26
 +0.59 / +1.98%
Today’s Change
11.34
Today|||52-Week Range
39.80
-21.12%
Year-to-Date
No recent news for Paratek Pharmaceuticals Inc.

Today’s Trading

Previous close29.82
Today’s open29.82
Day’s range29.10 - 31.45
Volume46,675
Average volume (3 months)32,102
Market cap$429.9M
Dividend yield2.20%
Data as of 02/26/2015

Growth & Valuation

Earnings growth (last year)-108.57%
Earnings growth (this year)+88.41%
Earnings growth (next 5 years)--
Revenue growth (last year)-81.80%
P/E ratioNM
Price/Sales36.10
Price/Book0.65

Competitors

 Today’s
change
Today’s
% change
VNDAVanda Pharmaceutical...+0.20+1.85%
TKMRTekmira Pharmaceutic...-1.04-5.35%
DRNADicerna Pharmaceutic...+1.03+4.31%
XNPTXenoport Inc+0.03+0.44%
Data as of 02/26/2015

Financials

Last reporting dateNovember 13, 2014
EPS forecast (this quarter)-$10.38
Annual revenue (last year)$1.7M
Annual profit (last year)-$27.4M
Net profit margin-1,571.04%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Michael F. Bigham
President, Director &
Chief Medical Officer
Evan Loh
Corporate headquarters
Boston, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account